University Innovation Doesn’t Need More Disconnected GAP Programs. It Needs GAP Systems.
GAP Insights | innovosource University innovation has made meaningful progress in developing Gap Fund and Accelerator Programs (GAP) that help research move toward commercialization. Pre-proof-of-concept initiatives, proof-of-concept funds, startup accelerators, and university venture funds have each become important components of the commercialization landscape. But an increasingly important question is emerging: Are we building connected GAP […]
GAP Pipeline Brief: University College London Inspire Innovation Fund Supports 26 Health Innovation Projects Through SPARK and TRACK Awards
Award & Investment Overview University College London (UCL) has announced 26 awards through the first call of its Inspire Innovation Fund (Health), supporting early-stage translational research projects across therapeutics, diagnostics, medical devices, and digital health. Administered through the UCL Translational Research Office (TRO), the fund is designed to help university researchers generate the technical and […]
GAP Pipeline Brief: Tulane University Awards $150,000 in Proof-of-Concept Funding to Advance Three Neuroscience and Therapeutic Innovations
Award & Investment Overview The Tulane Innovation Institute, in partnership with Provost Robin Forman, has awarded three Provost’s Proof of Concept (PPOC) Fund grants totaling $150,000 to university research teams developing technologies focused on the brain, nervous system, and neurological regulation of disease. Each project received $50,000 during the fund’s eighth funding cycle, with recipients […]
Ohio Third Frontier Awards $3.3 Million to Support Commercialization of Early Stage Technologies
The Ohio Third Frontier Commission today approved $3.3 million to support the research and commercialization of transformational early-stage technologies developed by startup companies and supported by research institutes across the state. There are seven organizations receiving grant funding to support further validation of early-stage technologies through the Technology Validation and Start-up Fund (TVSF), which provides […]
GAP Pipeline Brief: Yale School of Medicine-Founded Estuary Biotherapeutics Launches with $103 Million to Advance Kidney-Targeted Gene Therapies
Award & Investment Overview Estuary Biotherapeutics, a biotechnology company founded on research from Yale School of Medicine, has launched with $103 million in total committed financing to develop targeted gene therapies for serious kidney diseases. The financing includes a $93 million Series A led by RA Capital Management, following a $10 million seed round co-led […]
GAP Pipeline Brief: University of Oxford Spinout OMass Therapeutics Raises $310 Million Series C to Advance Endocrinology and Immunology Pipeline
Award & Investment Overview OMass Therapeutics, a University of Oxford spinout developing small-molecule medicines for complex biological targets, has secured an oversubscribed $310 million (£230 million) Series C financing round. The round was co-led by Bain Capital Life Sciences, Forbion, and Novo Holdings, with additional participation from Janus Henderson Investors, SV Health Investors, and Jefferson […]